Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis

J. C. Ayus, J. F. Eneas, Theodore G Tong, N. L. Benowitz, P. Y. Schoenfeld, K. L. Hadley, C. E. Becker, M. H. Humphreys

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Vancomycin is a useful antimicrobial agent in patients undergoing chronic hemodialysis treatment; its efficacy in chronic peritoneal dialysis (CPD) has not been established. Serum (V(S)) and peritoneal fluid (V(PF)) vancomycin concentrations were measured in two CPD patients with staphylococcal peritonitis. Half-life of V(S) agreed with the half-life of V(PF) in each patient and the V(S)/V(PF) ratio was 1.27 in both patients. Distribution volumes were 37.2 and 58.7 l, values approximating total body water in these patients. V(S) and V(PF) persisted in the therapeutic range (>5 μg/ml) for more than 16 days. In one patient, mean peritoneal clearance was 9.8 ml/min and overall drug clearance averaged 2.3 ml/min; in the other patient, overall clearance was 2.1 ml/min. These results indicate that therapeutic vancomycin levels can be maintained for more than 16 days with a single 1 g intravenous dose in patients receiving intermittent CPD, as is the case for hemodialysis patients. Because of this, parenteral vancomycin is useful in the treatment of staphylococcal peritonitis in CPD patients.

Original languageEnglish (US)
Pages (from-to)129-132
Number of pages4
JournalClinical Nephrology
Volume11
Issue number3
StatePublished - 1979
Externally publishedYes

Fingerprint

Peritoneal Dialysis
Vancomycin
Ascitic Fluid
Peritonitis
Half-Life
Renal Dialysis
Body Water
Therapeutics
Anti-Infective Agents

ASJC Scopus subject areas

  • Nephrology

Cite this

Ayus, J. C., Eneas, J. F., Tong, T. G., Benowitz, N. L., Schoenfeld, P. Y., Hadley, K. L., ... Humphreys, M. H. (1979). Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clinical Nephrology, 11(3), 129-132.

Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. / Ayus, J. C.; Eneas, J. F.; Tong, Theodore G; Benowitz, N. L.; Schoenfeld, P. Y.; Hadley, K. L.; Becker, C. E.; Humphreys, M. H.

In: Clinical Nephrology, Vol. 11, No. 3, 1979, p. 129-132.

Research output: Contribution to journalArticle

Ayus, JC, Eneas, JF, Tong, TG, Benowitz, NL, Schoenfeld, PY, Hadley, KL, Becker, CE & Humphreys, MH 1979, 'Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis', Clinical Nephrology, vol. 11, no. 3, pp. 129-132.
Ayus, J. C. ; Eneas, J. F. ; Tong, Theodore G ; Benowitz, N. L. ; Schoenfeld, P. Y. ; Hadley, K. L. ; Becker, C. E. ; Humphreys, M. H. / Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. In: Clinical Nephrology. 1979 ; Vol. 11, No. 3. pp. 129-132.
@article{2cf98227b6a7485cb73584b4b9819090,
title = "Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis",
abstract = "Vancomycin is a useful antimicrobial agent in patients undergoing chronic hemodialysis treatment; its efficacy in chronic peritoneal dialysis (CPD) has not been established. Serum (V(S)) and peritoneal fluid (V(PF)) vancomycin concentrations were measured in two CPD patients with staphylococcal peritonitis. Half-life of V(S) agreed with the half-life of V(PF) in each patient and the V(S)/V(PF) ratio was 1.27 in both patients. Distribution volumes were 37.2 and 58.7 l, values approximating total body water in these patients. V(S) and V(PF) persisted in the therapeutic range (>5 μg/ml) for more than 16 days. In one patient, mean peritoneal clearance was 9.8 ml/min and overall drug clearance averaged 2.3 ml/min; in the other patient, overall clearance was 2.1 ml/min. These results indicate that therapeutic vancomycin levels can be maintained for more than 16 days with a single 1 g intravenous dose in patients receiving intermittent CPD, as is the case for hemodialysis patients. Because of this, parenteral vancomycin is useful in the treatment of staphylococcal peritonitis in CPD patients.",
author = "Ayus, {J. C.} and Eneas, {J. F.} and Tong, {Theodore G} and Benowitz, {N. L.} and Schoenfeld, {P. Y.} and Hadley, {K. L.} and Becker, {C. E.} and Humphreys, {M. H.}",
year = "1979",
language = "English (US)",
volume = "11",
pages = "129--132",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "3",

}

TY - JOUR

T1 - Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis

AU - Ayus, J. C.

AU - Eneas, J. F.

AU - Tong, Theodore G

AU - Benowitz, N. L.

AU - Schoenfeld, P. Y.

AU - Hadley, K. L.

AU - Becker, C. E.

AU - Humphreys, M. H.

PY - 1979

Y1 - 1979

N2 - Vancomycin is a useful antimicrobial agent in patients undergoing chronic hemodialysis treatment; its efficacy in chronic peritoneal dialysis (CPD) has not been established. Serum (V(S)) and peritoneal fluid (V(PF)) vancomycin concentrations were measured in two CPD patients with staphylococcal peritonitis. Half-life of V(S) agreed with the half-life of V(PF) in each patient and the V(S)/V(PF) ratio was 1.27 in both patients. Distribution volumes were 37.2 and 58.7 l, values approximating total body water in these patients. V(S) and V(PF) persisted in the therapeutic range (>5 μg/ml) for more than 16 days. In one patient, mean peritoneal clearance was 9.8 ml/min and overall drug clearance averaged 2.3 ml/min; in the other patient, overall clearance was 2.1 ml/min. These results indicate that therapeutic vancomycin levels can be maintained for more than 16 days with a single 1 g intravenous dose in patients receiving intermittent CPD, as is the case for hemodialysis patients. Because of this, parenteral vancomycin is useful in the treatment of staphylococcal peritonitis in CPD patients.

AB - Vancomycin is a useful antimicrobial agent in patients undergoing chronic hemodialysis treatment; its efficacy in chronic peritoneal dialysis (CPD) has not been established. Serum (V(S)) and peritoneal fluid (V(PF)) vancomycin concentrations were measured in two CPD patients with staphylococcal peritonitis. Half-life of V(S) agreed with the half-life of V(PF) in each patient and the V(S)/V(PF) ratio was 1.27 in both patients. Distribution volumes were 37.2 and 58.7 l, values approximating total body water in these patients. V(S) and V(PF) persisted in the therapeutic range (>5 μg/ml) for more than 16 days. In one patient, mean peritoneal clearance was 9.8 ml/min and overall drug clearance averaged 2.3 ml/min; in the other patient, overall clearance was 2.1 ml/min. These results indicate that therapeutic vancomycin levels can be maintained for more than 16 days with a single 1 g intravenous dose in patients receiving intermittent CPD, as is the case for hemodialysis patients. Because of this, parenteral vancomycin is useful in the treatment of staphylococcal peritonitis in CPD patients.

UR - http://www.scopus.com/inward/record.url?scp=0018741594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018741594&partnerID=8YFLogxK

M3 - Article

C2 - 436339

AN - SCOPUS:0018741594

VL - 11

SP - 129

EP - 132

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 3

ER -